Pfizer Withdraws Request for Depo-Provera Litigation Coordination in Philadelphia Amid Lack of New Cases
Philadelphia — A coordinated mass tort regarding Depo-Provera, Pfizer Inc.’s injectable contraceptive, will not proceed in the city for now. The pharmaceutical giant has recently withdrawn its request for the Philadelphia Court of Common Pleas to establish a consolidated litigation program concerning this contraceptive, citing an unexpected lack of new lawsuits. Pfizer’s decision comes after expectations of a significant increase in legal filings surrounding the product failed to materialize. The company’s initial proposal aimed to streamline the process for addressing multiple claims against Depo-Provera, but the anticipated surge in litigation has not occurred. Depo-Provera, a … Read more